Micellar Solution of [

Radium-223 dichloride anticancer effect biochemical changes micellar solution nanotechnology pharmacokinetics renal excretion

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
07 Jan 2024
Historique:
received: 20 05 2023
revised: 27 11 2023
accepted: 31 12 2023
medline: 10 1 2024
pubmed: 10 1 2024
entrez: 9 1 2024
Statut: aheadofprint

Résumé

Despite the successful use of the radiopharmaceutical radium-223 dichloride ([

Identifiants

DOI: 10.1016/j.ijpharm.2023.123765 PMID: 38195032
pubmed: 38195032
pii: S0378-5173(23)01187-0
doi: 10.1016/j.ijpharm.2023.123765
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123765

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Martha Sahylí Ortega Pijeira (M)

Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil.

Natália Cristina Gomes da Silva (N)

Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil.

Eduardo Ricci-Junior (E)

School of Pharmacy, DEFARMED, Rio de Janeiro Federal University, Rio de Janeiro 21941900, Brazil.

Luciana Magalhães Rebelo Alencar (L)

Department of Physics, Laboratory of Biophysics and Nanosystems, Federal University of Maranhão, Maranhão 65080-805, Brazil.

Derya İlem-Özdemir (D)

School of Pharmacy, Department of Radiopharmacy, Ege University, 35040, Bornova, Izmir, Turkey.

Amanda Dos Santos Cavalcanti (A)

Research Division, National Institute of Traumatology and Orthopedics, Rio de Janeiro 20940-070, Brazil; State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil.

Daniel Escorsim Machado (D)

State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil.

Jamila Alessandra Perini (J)

State University of Rio de Janeiro, Research Laboratory of Pharmaceutical Sciences, Rio de Janeiro 23070200, Brazil.

Ralph Santos-Oliveira (R)

Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro 21941906, Brazil; State University of Rio de Janeiro, Laboratory of Radiopharmacy and Nanoradiopharmaceuticals, Rio de Janeiro 23070200, Brazil. Electronic address: roliveira@ien.gov.br.

Classifications MeSH